Heusinkveld, Lauren E.
Majumdar, Shamik
Gao, Ji-Liang
McDermott, David H.
Murphy, Philip M. http://orcid.org/0000-0002-1080-8201
Funding for this research was provided by:
National Institutes of Health (AI000615-28)
Article History
Received: 22 April 2019
Accepted: 26 June 2019
First Online: 16 July 2019
Compliance with Ethical Standards
:
: PMM is a member of the Scientific Advisory Board of X4-Pharma. PMM, J-LG, and DHM are listed as inventors on a patent application disclosing a method of enhancing hematopoietic stem cell engraftment by CXCR4 knockdown. There are no other stated conflicts of interest.